Physician profile
Wayne L Sager
NPI 1225182314
$2,719.02
in general payments reported to CMS, 2019-2025
14 companies · $335 in 2025
The $335 reported for 2025 was more than what 87% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $181 · 2020: $12.00 · 2021: $599 · 2022: $511 · 2023: $689 · 2024: $392 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,416.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $885.47 | 2021-2025 | Azstarys |
| Glaxosmithkline, LLC. | $452.33 | 2019-2024 | Bexsero, Pediarix, Rotarix |
| Supernus Pharmaceuticals, INC. | $405.22 | 2021-2025 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $239.49 | 2019-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Tris Pharma INC | $219.33 | 2021-2023 | Dyanavel Xr, Quillichew Er |
| Sanofi Pasteur INC. | $156.68 | 2019-2025 | |
| Sobi, INC | $115.27 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.79 | 2021 | |
| Pfizer INC. | $69.11 | 2021-2023 | |
| Cranial Technologies, INC | $32.41 | 2024-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $21.43 | 2019 | |
| Alexion Pharmaceuticals, INC. | $21.14 | 2023 | Koselugo |
| Shire North American Group INC | $13.93 | 2019 | |
| Sarepta Therapeutics, INC. | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Sager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.